MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Tools for prostate cancer screening

Back to prostate cancer blog Blogs list Cancer blog  


Subscribe To Prostate Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Tools for prostate cancer screening




Eventhough screening for prostate cancer with the Prostate Specific Antigen (PSA) test in men ages 50-70 can detect the cancer before it becomes symptomatic, knowing whether screening is beneficial for these men is uncertain.

Recent trials have shown small or no reductions in prostate cancer mortality among those screened. The small potential for benefit must be balanced against the more common and immediate downsides of increasing the chance of prostate cancer diagnosis and therapy-related complications.

Developing more effective decision support tools may help men and their physicians discuss whether or not to undertake PSA screening.



Tools for prostate cancer screening
Michael Pignone, M.D., M.P.H., from the University of North Carolina School of Medicine.


Michael Pignone, M.D., M.P.H., authored an editorial in the Sept. 28 Archives of Internal Medicine about this issue. He evaluated two studies: one from the National Survey of Medical Decisions and a second study from Australia that modeled the potential effects of screening for use in discussions about screening.

Pignone is associate professor of medicine and chief of the division of general internal medicine in the UNC School of Medicine and a member of UNC Lineberger Comprehensive Cancer Center.

He explained, "To make a good decision about whether or not to be screened, patients need to know their chances of being helped by screening and their chances of being harmed".

"The National Survey of Medical Decisions suggests that patients are not being regularly informed about the advantages and disadvantages of screening. The downsides of screening were talked about in only 32 percent of the discussions. Half of the patients couldn't answer any of the knowledge questions correctly about screening risks.

The Australian study provides updated data for such conversations: screening increases the chance of being diagnosed with prostate cancer from 23 per 1000 to 53 per 1000 over 10 years. The number of men with therapy related impotence or incontinence would also be twice as common: about 26 per 1000 vs. 12 per 1000. The chance of death from prostate cancer would be reduced from 4 in 1000 to 3 in 1000".

"The next step is to study whether providing patients with such information and determining if it changes their knowledge and preferences about screening".


Posted by: Mark    Source




Did you know?
Eventhough screening for prostate cancer with the Prostate Specific Antigen (PSA) test in men ages 50-70 can detect the cancer before it becomes symptomatic, knowing whether screening is beneficial for these men is uncertain. Recent trials have shown small or no reductions in prostate cancer mortality among those screened. The small potential for benefit must be balanced against the more common and immediate downsides of increasing the chance of prostate cancer diagnosis and therapy-related complications.

Medicineworld.org: Tools for prostate cancer screening

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.